VANDA PHARMACEUTICALS INC. (VNDA) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $60.00K; Additional Paid in Capital, Common StockUSD $725.93M; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $47.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $60.00K; Additional Paid in Capital, Common StockUSD $723.83M; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $52.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $59.00K; Additional Paid in Capital, Common StockUSD $721.26M; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $68.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $59.00K; Additional Paid in Capital, Common StockUSD $718.98M; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $69.00K.
VANDA PHARMACEUTICALS INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $60.00K | $725.93M | $47.00K | $-9.00K | $38.00K | $-505.85M | $220.19M | 3 month · $2.11M | (m) |
| 2026-03-31 | $0.00 | $60.00K | $723.83M | $52.00K | $160.00K | $212.00K | $-443.33M | $280.76M | 3 month · $2.56M | (m) |
| 2025-12-31 | $0.00 | $59.00K | $721.26M | $68.00K | $561.00K | $629.00K | $-394.77M | $327.19M | 12 month · $9.47M | (m) |
| 2025-09-30 | $0.00 | $59.00K | $718.98M | $69.00K | $471.00K | $540.00K | $-253.58M | $466.00M | 3 month · $2.11M | (m) |
| 2025-06-30 | $0.00 | $59.00K | $716.87M | $72.00K | $324.00K | $396.00K | $-230.99M | $486.33M | 3 month · $2.11M | (m) |
| 2025-03-31 | $0.00 | $59.00K | $714.76M | $12.00K | $371.00K | $383.00K | $-203.79M | $511.42M | 3 month · $2.97M | (m) |
| 2024-12-31 | $0.00 | $58.00K | $712.71M | $-13.00K | $87.00K | $74.00K | $-174.29M | $538.55M | 12 month · $12.43M | (m) |
| 2024-09-30 | $0.00 | $58.00K | $709.84M | $35.00K | $667.00K | $702.00K | $-169.38M | $541.22M | 3 month · $3.00M | (m) |
| 2024-06-30 | $0.00 | $58.00K | $706.84M | $-1.00K | $-329.00K | $-330.00K | $-164.06M | $542.52M | 3 month · $2.99M | (m) |
| 2024-03-31 | $0.00 | $58.00K | $703.86M | $2.00K | $-385.00K | $-383.00K | $-159.54M | $544.00M | 3 month · $3.58M | (m) |
| 2023-12-31 | $0.00 | $58.00K | $700.27M | $21.00K | $-51.00K | $-30.00K | $-155.39M | $544.91M | 12 month · $14.04M | (m) |
| 2023-09-30 | $0.00 | $58.00K | $697.00M | $-13.00K | $-954.00K | $-967.00K | $-152.99M | $543.10M | 3 month · $3.17M | (m) |
| 2023-06-30 | $0.00 | $57.00K | $693.84M | $5.00K | $-870.00K | $-865.00K | $-153.13M | $539.90M | 3 month · $3.25M | (m) |
| 2023-03-31 | $0.00 | $57.00K | $690.59M | $2.00K | $-257.00K | $-255.00K | $-154.65M | $535.74M | 3 month · $4.35M | (m) |
| 2022-12-31 | $0.00 | $57.00K | $686.24M | $-7.00K | $-1.19M | $-1.19M | $-157.90M | $527.20M | 12 month · $16.28M | (m) |
| 2022-09-30 | $0.00 | $57.00K | $681.85M | $-51.00K | $-1.43M | $-1.49M | $-164.76M | $515.66M | 3 month · $3.89M | (m) |
| 2022-06-30 | $0.00 | $57.00K | $677.96M | $-14.00K | $-1.42M | $-1.43M | $-168.03M | $508.55M | 3 month · $3.83M | (m) |
| 2022-03-31 | $0.00 | $56.00K | $674.00M | $16.00K | $-1.34M | $-1.33M | $-170.61M | $502.12M | 3 month · $4.78M | (m) |
| 2021-12-31 | $0.00 | $56.00K | $669.22M | $32.00K | $-207.00K | $-175.00K | $-164.18M | $504.93M | 12 month · $15.37M | (m) |
| 2021-09-30 | $0.00 | $56.00K | $664.41M | $33.00K | $78.00K | $111.00K | $-171.25M | $493.32M | 3 month · $3.95M | (m) |
| 2021-06-30 | $0.00 | $56.00K | $660.09M | $50.00K | $53.00K | $103.00K | $-179.03M | $481.22M | 3 month · $3.74M | (m) |
| 2021-03-31 | $0.00 | $56.00K | $656.06M | $34.00K | $158.00K | $192.00K | $-188.68M | $467.63M | 3 month · $3.91M | (m) |
| 2020-12-31 | $0.00 | $55.00K | $650.30M | $81.00K | $158.00K | $239.00K | $-197.33M | $453.27M | 12 month · $13.36M | (m) |
| 2020-09-30 | $0.00 | $55.00K | $645.66M | $42.00K | $337.00K | $379.00K | $-205.52M | $440.57M | 3 month · $3.13M | (m) |
| 2020-06-30 | $0.00 | $55.00K | $642.40M | $10.00K | $586.00K | $596.00K | $-211.47M | $431.58M | 3 month · $3.07M | (m) |
| 2020-03-31 | $0.00 | $54.00K | $635.73M | $0.00 | $781.00K | $781.00K | $-220.18M | $416.39M | 3 month · $3.94M | (m) |
| 2019-12-31 | $0.00 | $54.00K | $631.31M | $13.00K | $236.00K | $249.00K | $-220.66M | $410.94M | 12 month · $13.46M | (m) |
| 2019-09-30 | $0.00 | $53.00K | $625.52M | $-10.00K | $221.00K | $211.00K | $-224.88M | $400.91M | 3 month · $3.41M | (m) |
| 2019-06-30 | $0.00 | $53.00K | $621.56M | $9.00K | $377.00K | $386.00K | $-325.30M | $296.69M | 3 month · $3.10M | (m) |
| 2019-03-31 | $0.00 | $53.00K | $615.05M | $3.00K | $132.00K | $135.00K | $-336.83M | $278.40M | 3 month · $3.28M | (m) |
| 2018-12-31 | $0.00 | $52.00K | $611.59M | $7.00K | $-6.00K | $1.00K | $-336.22M | $275.42M | 12 month · $11.67M | (m) |
| 2018-09-30 | $0.00 | $52.00K | $607.87M | $14.00K | $56.00K | $70.00K | $-346.58M | $261.42M | 3 month · $2.87M 9 month · $8.74M | (m) |
| 2018-06-30 | $0.00 | $52.00K | $604.89M | $16.00K | $63.00K | $79.00K | $-353.75M | $251.27M | 3 month · $2.72M 6 month · $5.87M | (m) |
| 2018-03-31 | (m) | $52.00K | $599.48M | $41.00K | $-69.00K | $-28.00K | $-358.36M | $241.14M | 3 month · $3.15M | (m) |
| 2017-12-31 | $0.00 | $45.00K | $492.80M | $29.00K | $-63.00K | $-34.00K | $-361.43M | $131.39M | 12 month · $10.46M | (m) |
| 2017-09-30 | (m) | $45.00K | $489.94M | (m) | (m) | $73.00K | $-359.59M | $130.47M | 9 month · $7.68M | (m) |
| 2017-06-30 | (m) | $45.00K | $486.40M | (m) | (m) | $11.00K | $-355.04M | $131.42M | 6 month · $4.91M | (m) |
| 2017-03-31 | (m) | $45.00K | $481.55M | (m) | (m) | $50.00K | $-353.50M | $128.14M | 3 month · $2.26M | (m) |
| 2016-12-31 | (m) | $44.00K | $477.09M | $-1.00K | $59.00K | $58.00K | $-345.86M | $131.33M | 12 month · $8.54M | (m) |
| 2016-09-30 | (m) | $44.00K | $474.23M | (m) | (m) | $142.00K | $-345.25M | $129.16M | 9 month · $6.44M | (m) |
| 2016-06-30 | (m) | $43.00K | $466.27M | (m) | (m) | $124.00K | $-344.82M | $121.61M | 6 month · $4.34M | (m) |
| 2016-03-31 | (m) | $43.00K | $463.08M | (m) | (m) | $92.00K | $-340.21M | $123.01M | 3 month · $2.27M | (m) |
| 2015-12-31 | (m) | $43.00K | $460.79M | (m) | (m) | $39.00K | $-327.85M | $133.03M | 12 month · $7.96M | (m) |
| 2015-09-30 | (m) | $43.00K | $458.91M | (m) | (m) | $37.00K | $-313.05M | $145.94M | 9 month · $6.07M | (m) |
| 2015-06-30 | (m) | $42.00K | $453.27M | (m) | (m) | $27.00K | $-303.59M | $149.75M | 6 month · $4.01M | (m) |
| 2015-03-31 | (m) | $42.00K | $450.61M | (m) | (m) | $27.00K | $-298.20M | $152.47M | 3 month · $1.95M | (m) |
| 2014-12-31 | (m) | $41.00K | $448.74M | (m) | (m) | $16.00K | $-287.98M | $160.82M | 12 month · $5.88M | (m) |
| 2014-09-30 | $0.00 | $34.00K | $358.73M | (m) | (m) | $4.00K | $-357.70M | $1.06M | 9 month · $4.25M | (m) |
| 2014-06-30 | $0.00 | $34.00K | $357.12M | (m) | $10.00K | (m) | $-356.28M | $885.00K | 6 month · $2.84M | (m) |
| 2014-03-31 | (m) | $34.00K | $355.64M | (m) | $8.00K | (m) | $-334.70M | $20.98M | 3 month · $1.39M | (m) |
| 2013-12-31 | $0.00 | $33.00K | $352.24M | (m) | $21.00K | $21.00K | $-308.17M | $44.12M | 12 month · $5.40M | (m) |
| 2013-09-30 | (m) | $33.00K | $353.71M | (m) | (m) | (m) | $-303.74M | $50.00M | 9 month · $3.32M | (m) |
| 2013-06-30 | (m) | $28.00K | $303.36M | (m) | (m) | (m) | $-298.36M | $5.03M | 6 month · $1.78M | (m) |
| 2013-03-31 | (m) | $28.00K | $301.73M | (m) | (m) | (m) | $-295.28M | $6.48M | 3 month · $952.00K | (m) |
| 2012-12-31 | (m) | $28.00K | $300.97M | (m) | $10.00K | $10.00K | $-291.11M | $9.90M | 12 month · $5.05M | (m) |
| 2012-09-30 | (m) | $28.00K | $300.04M | (m) | (m) | $23.00K | $-284.74M | $15.35M | (m) | (m) |
| 2012-06-30 | (m) | $28.00K | $299.46M | (m) | (m) | $5.00K | $-279.41M | $20.08M | (m) | (m) |
| 2012-03-31 | (m) | $28.00K | $298.27M | (m) | (m) | $27.00K | $-271.40M | $26.92M | (m) | (m) |
| 2011-12-31 | (m) | $28.00K | $296.87M | (m) | (m) | $21.00K | $-263.44M | $33.47M | 12 month · $5.50M | (m) |
| 2011-09-30 | (m) | $28.00K | $295.53M | (m) | (m) | $44.00K | $-257.92M | $37.68M | (m) | (m) |
| 2011-06-30 | $0.00 | $28.00K | $294.27M | (m) | (m) | $85.00K | $-254.85M | $39.54M | (m) | (m) |
| 2010-12-31 | $0.00 | $28.00K | $291.34M | (m) | (m) | $2.00K | $-253.64M | $37.73M | 12 month · $4.98M | 12 month · $1.63M |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $23.03M | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $46.02M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |